S
69.80
0.86 (1.25%)
| Previous Close | 68.94 |
| Open | 69.24 |
| Volume | 1,210,641 |
| Avg. Volume (3M) | 1,328,196 |
| Market Cap | 3,709,521,152 |
| Price / Sales | 100.10 |
| Price / Book | 15.85 |
| 52 Weeks Range | |
| Earnings Date | 5 Nov 2025 |
| Diluted EPS (TTM) | -4.74 |
| Total Debt/Equity (MRQ) | 22.73% |
| Current Ratio (MRQ) | 19.64 |
| Operating Cash Flow (TTM) | -89.32 M |
| Levered Free Cash Flow (TTM) | -33.98 M |
| Return on Assets (TTM) | -52.40% |
| Return on Equity (TTM) | -105.54% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Soleno Therapeutics, Inc. | Bullish | Bullish |
AIStockmoo Score
1.0
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -1.5 |
| Technical Oscillators | -0.5 |
| Average | 1.00 |
|
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 1.83% |
| % Held by Institutions | 109.24% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Holocene Advisors, Lp | 30 Jun 2025 | 1,153,048 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 123.00 (Wells Fargo, 76.22%) | Buy |
| Median | 110.00 (57.59%) | |
| Low | 106.00 (Guggenheim, 51.86%) | Buy |
| Average | 114.00 (63.32%) | |
| Total | 5 Buy | |
| Avg. Price @ Call | 75.20 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 20 Aug 2025 | 123.00 (76.22%) | Buy | 68.94 |
| HC Wainwright & Co. | 18 Aug 2025 | 110.00 (57.59%) | Buy | 68.09 |
| Guggenheim | 07 Aug 2025 | 106.00 (51.86%) | Buy | 78.71 |
| Oppenheimer | 07 Aug 2025 | 110.00 (57.59%) | Buy | 78.71 |
| Baird | 11 Jul 2025 | 121.00 (73.35%) | Buy | 81.57 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |